Tuberculosis in the European Union and European Economic Area: a survey of national tuberculosis programmes Source: Eur Respir J, 52 (6) 1801449; 10.1183/13993003.01449-2018 Year: 2018
Fighting tuberculosis in the EU/EEA: towards the new European Union standards on tuberculosis care Source: Eur Respir J 2016; 48: 1278-1281 Year: 2016
Towards tackling tuberculosis in vulnerable groups in the European Union: the E-DETECT TB consortium Source: Eur Respir J, 51 (5) 1702604; 10.1183/13993003.02604-2017 Year: 2018
TB and MDR/XDR-TB in European Union and European Economic Area countries: managed or mismanaged? Source: Eur Respir J 2012; 39: 619-625 Year: 2012
Tuberculosis and HIV co-infection in European Union and European Economic Area countries Source: Eur Respir J 2011; 38: 1382-1392 Year: 2011
ERS/ECDC updated European Union standards of tuberculosis care Source: International Congress 2018 – Important changes in the management of tuberculosis Year: 2018
European Union standard for tuberculosis care on treatment of multidrug-resistant tuberculosis following new World Health Organization recommendations Source: Eur Respir J, 52 (5) 1801617; 10.1183/13993003.01617-2018 Year: 2018
Drug resistance among tuberculosis cases in the European Union and European Economic Area, 2007 to 2012 Source: International Congress 2014 – Tuberculosis: public health and primary prevention Year: 2014
Eligibility for shorter treatment of multidrug-resistant tuberculosis in the European Union Source: Eur Respir J , 49 (3) 1601992; DOI: 10.1183/13993003.01992-2016 Year: 2017
Comparison of tuberculosis surveillance systems in low-incidence industrialised countries Source: Eur Respir J 2008; 32: 1616-1624 Year: 2008
European Union Standards for Tuberculosis Care Source: Eur Respir J 2012; 39: 807-819 Year: 2012
Estimation of XDR-TB in European part of the Russian Federation Source: International Congress 2016 – Rifampicin resistance, MDRTB, and new drug treatments Year: 2016
European framework for tuberculosis control and elimination in countries with a low incidence: Recommendations of the World Health Organization (WHO), International Union Against Tuberculosis and Lung Disease (IUATLD) and Royal Netherlands Tuberculosis Source: Eur Respir J 2002; 19: 765-775 Year: 2002
Tuberculosis screening in migrants in selected European countries shows wide disparities Source: Eur Respir J 2006; 27: 801-807 Year: 2006
Guidance for programmatic management of latent tuberculosis infection in the European Union/European Economic Area Source: Eur Respir J, 53 (1) 1802077; 10.1183/13993003.02077-2018 Year: 2019
Management of tuberculosis in the European Union: a multicentre audit Source: International Congress 2018 – New developments in tuberculosis Year: 2018
Romanian emigrants developing tuberculosis while working in European countries Source: Annual Congress 2008 - Tuberculosis in immigrants, disadvantaged populations, elderly, HIV-seropositives and in other risk groups Year: 2008
Drug resistance of Mycobacterium tuberculosis in the Ural region of Russian Federation Source: International Congress 2019 – Tuberculosis: from diagnosis to complications Year: 2019
Drug susceptibility of slowly growing nontuberculous mycobacteria (sNTM) isolated in the European part of Russian Federation Source: International Congress 2018 – Challenges in treating tuberculosis and nontuberculous mycobacteria Year: 2018
The European Union standards for tuberculosis care: do they need an update? Source: Eur Respir J 2014; 43: 933-942 Year: 2014